Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Goodwill: 2017-2024

Historic Goodwill for Adma Biologics (ADMA) over the last 7 years, with Dec 2024 value amounting to $3.5 million.

  • Adma Biologics' Goodwill changed negligibly% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.5 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Adma Biologics reported Goodwill of $3.5 million as of FY2024, which was down 0.00% from $3.5 million recorded in FY2023.
  • In the past 5 years, Adma Biologics' Goodwill registered a high of $3.5 million during FY2022, and its lowest value of $3.5 million during FY2020.
  • Moreover, its 3-year median value for Goodwill was $3.5 million (2024), whereas its average is $3.5 million.
  • Data for Adma Biologics' Goodwill shows a peak YoY increased of 0.01% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Adma Biologics' Goodwill stood at $3.5 million in 2020, then remained steady at $3.5 million in 2021, then climbed by 0.01% to $3.5 million in 2022, then remained steady at $3.5 million in 2023, then remained steady at $3.5 million in 2024.